Global Expansion TCG has an international footprint with offices in the US and Europe and expanded operations into Japan, suggesting a readiness to support cross-border deals, market entry strategies, and multinational licensing or partnership opportunities in life sciences.

Senior-Led Advantage The firm offers senior partner leadership with 25+ years of industry experience, a strong differentiator for high-stakes transactions such as licensing, M&A, and strategic partnerships, appealing to clients seeking credible, executive-level deal governance.

Life Science Focus Specialization spans medical devices, diagnostics, pharma, biotech, digital health, and health IT, indicating cross-domain opportunities to structure integrated commercialization plans, strategic alliances, and asset sales across multiple life science sub-sectors.

Interim Management Capability to provide interim executives for critical projects or market entry offers a sales angle to serve clients needing temporary leadership, facilitating faster deal execution and market launches.

Strategic Partnerships History of advising on licensing, M&A, distribution agreements, and financings, plus a track record with MedTech Innovator, positions TCG as a valuable partner for accelerators, incubators, and early-stage companies seeking to de-risk and scale commercial opportunities.